Randy Milby bought $5,221 of CNTN
CEO at Tharimmune, Inc.. 2,500 shares at an average of $2.09, traded Oct 8, 2024, filed Oct 10, 2024.
Score components
- +25RoleCEO
- 0Trade size$5k at market
- +6Relative to holdingsHoldings up 24%
- +18Price context6% above the 52-week low; 98% below the 52-week high
- +8Cluster2 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (2 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001493152-24-040736, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 8, 2024 | POpen-market purchase Common Stock | +1,500 | $2.09 | $3,128 | 11,934 | Oct 10, 2024 |
| Oct 8, 2024 | POpen-market purchase Common Stock | +646 | $2.09 | $1,350 | 12,580 | Oct 10, 2024 |
| Oct 8, 2024 | POpen-market purchase Common Stock | +354 | $2.10 | $743 | 12,934 | Oct 10, 2024 |
Related signals
Other insiders at Tharimmune, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 40Moderate | CNTNsell Tharimmune, Inc. | Gary S. Stetz director | $344k 100,351 shares | -43% | |
| 67Notable | Tharimmune, Inc. | Sireesh Appajosyula Chief Executive Officer | $91k 61,496 shares | +1824% | |
| 71Notable | Tharimmune, Inc. | Gravitas Capital LP Executive Chairman | $500k 337,838 shares | +86% | |
| 53Moderate | Tharimmune, Inc. | Sanam Parikh COO | $1,450 1,000 shares | +130% | |
| 31Weak | CNTNbuy Tharimmune, Inc. | Sanam Parikh COO | $1,001 770 shares | - | |
| 31Weak | CNTNbuy Tharimmune, Inc. | Randy Milby CEO | $9,752 4,600 shares | +36% | |
| 30Weak | CNTNbuy Tharimmune, Inc. | Sireesh Appajosyula Chief Operating Officer | $10k 5,000 shares | +87% | |
| 56Moderate | Tharimmune, Inc. | Sireesh Appajosyula Chief Operating Officer | $9,650 5,000 shares | +660% | |
| 52Moderate | Tharimmune, Inc. | Sireesh Appajosyula Chief Operating Officer | $9,650 5,000 shares | +44% | |
| 44Moderate | CNTNbuy Tharimmune, Inc. | Randy Milby CEO | $15k 29,000 shares | +23% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.